SLATE
Live / Registered — Registered (as of 28 Jun 2022)
What this means for you
Registered since 28 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88030324
- Registration number
- 6775121
- Mark type
- Stylized text
- Filed
- 09 Jul 2018
- Published for opposition
- 24 Dec 2019
- Registered
- 28 Jun 2022
- Attorney of record
- Fidel Nwamu
Goods and services
- Class 042 — Scientific and technological services: Conducting evaluations in the field of pharmaceuticals; pharmaceutical product development and evaluation services; pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients
Owner
- GRITSTONE BIO, INC., Emeryville, CA, US
- GRITSTONE BIO, INC., Emeryville, CA, US
- Gritstone Oncology, Inc., Emeryville, CA, US
- Gritstone Oncology, Inc., Emeryville, CA, US
Prosecution history
- 28 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 21 May 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 May 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 May 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 May 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 May 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Apr 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Apr 2022 — NON-FINAL ACTION E-MAILED
- 01 Apr 2022 — SU - NON-FINAL ACTION - WRITTEN
- 02 Mar 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Feb 2022 — USE AMENDMENT FILED
- 02 Mar 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Feb 2022 — TEAS STATEMENT OF USE RECEIVED
- 20 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED